Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteogenesis imperfecta: contribution to pathobiochemistry].

B F Pontz, P K Müller

    Padiatrie Und Padologie
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline.

    Journal of chromatography. A·2011
    Same author

    [A 32-year old male patient with pathological humeral fracture, splenomegaly and thrombocytopenia].

    Der Internist·2004
    Same author

    The multi-KH protein vigilin associates with free and membrane-bound ribosomes.

    Cellular and molecular life sciences : CMLS·2003
    Same author

    Evidence for posttranscriptional regulation of the multi K homology domain protein vigilin by a small peptide encoded in the 5' leader sequence.

    Cellular and molecular life sciences : CMLS·2003
    Same author

    T-cell-depleted peripheral blood stem cell transplantation for alpha-mannosidosis.

    Bone marrow transplantation·2003
    Same author

    Estradiol has a direct impact on the exocrine pancreas as demonstrated by enzyme and vigilin expression.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2002
    Same journal

    [Is the Supply of Medicines in Danger?]

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    Same journal

    Padiatrie und Padologie·2023
    See all related articles

    Osteogenesis imperfecta (OI), a brittle bone disease, involves collagen defects. Biochemical analysis of collagen aids in classifying OI patients, especially those uncategorized by current methods.

    Area of Science:

    • Biochemistry
    • Genetics
    • Connective Tissue Diseases

    Context:

    • Osteogenesis imperfecta (OI) is a hereditary disorder causing bone fragility and deformities.
    • It's a generalized connective tissue disorder with symptoms like blue sclerae and dentinogenesis imperfecta.
    • Sillence classification categorizes OI into four main groups based on clinical and genetic traits.

    Purpose:

    • To investigate metabolic alterations in connective tissue components, specifically collagen, in patients with Osteogenesis imperfecta.
    • To analyze synthesized collagen types and their hydroxylation in different OI groups.
    • To evaluate the utility of biochemical collagen examination for classifying OI patients.

    Summary:

    • Collagen analysis revealed elevated type III collagen in OI group I fibroblasts (15-48%).

    Related Experiment Videos

  • Groups II and III showed increased hydroxylysine in collagen types I and III, with slightly elevated lysyl hydroxylation in type II collagen.
  • Collagen in OI group IV appeared normal; biochemical findings sometimes aligned with clinical presentations across groups, aiding differentiation.

    • Impact:

    • Biochemical examination of collagen provides complementary data for differentiating OI subtypes.
    • This approach can help classify patients who don't fit neatly into existing clinical or genetic categories.
    • Understanding collagen alterations improves diagnostic accuracy and potential therapeutic strategies for Osteogenesis imperfecta.